Navigation Links
Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Date:8/20/2007

Quark's First Hearing Loss Compound, AHLi-11, Slated for IND Filing By

Year- End 2007

FREMONT, Calif., Aug. 20 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel RNA interference-based therapeutics, announced today that it has expanded its relationship with the State University of New York at Buffalo, Center for Hearing & Deafness, which is the Company's primary site for the pre-clinical studies of its product candidate, AHLi-11, for the treatment of acute hearing loss. Quark initiated its collaboration with the State University of New York in 2005.

The current studies, led by Professor Richard Salvi, focus on the in-depth analysis of the effect of AHLi-11 and other molecules in preventing chemotherapy induced hearing loss. Based on these studies, Quark Pharmaceuticals expects to file an IND within 2007 for AHLi-11 for the prevention chemotherapy-induced hearing loss.

AHLi-11 is a siRNA-based drug that temporarily inhibits the expression of human gene p53. Cochlear hair cell apoptosis (cell death), a key factor in several of the more common causes of acute hearing loss, is believed to be induced by molecular mechanisms most likely associated with p53-dependent stress response. Inhibition of p53, therefore, is suggested as a potential modality for the prevention of ototoxic hearing loss, a common side effect of certain drugs including aminoglycoside antibiotics and cancer therapeutics such as cisplatin, as well as acoustic trauma.

Quark has demonstrated delivery of siRNA into target cells in rats and monkeys along with its persistence in the cochlear hair cells for at least 15 days. In preclinical animal studies, AHLi-11 appears to protect cochlear hair cells from apoptotic cell death induced by the chemotherapeutic agents, cisplatin and carboplatin, and by acoustic trauma.

Daniel Zurr, CEO of Quark Pharmaceuticals, sa
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Dr. Michael Gabriel of a prominent Staten ... study, which shows how grief in pregnancy may cause obesity ... According to US News , "Unborn children ... others to grow up overweight or obese, even if that ... specific types of stress that caused obesity: "Children whose biological ...
(Date:7/24/2014)... 2014   AcelRx Pharmaceuticals, Inc.  (Nasdaq: ... development and commercialization of innovative therapies for the treatment ... date for Zalviso remains July 27, 2014.  ... stating the Food and Drug Administration (FDA) had approved ... no notification to the company from the FDA regarding ...
(Date:7/24/2014)... PARK, Kan. , July 24, 2014 /PRNewswire/ ... of two compounds that will be added to ... with Australian-based CIMTECH Pty Ltd, a biotechnology company. ... PAR 122 have shown promise in bone regeneration ... license to develop the compounds for the veterinary ...
Breaking Medicine Technology:Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children 2AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4
(Date:7/25/2014)... July 25, 2014 Mahendra Trivedi and ... Online Workshop ‘Consciousness is Power’ on Saturday, July 26, ... to attend this life transforming event as they will ... higher level. Few days are left for the commencement ... Trivedi and Trivedi Masters™ Dahryn Trivedi (his wife) and ...
(Date:7/25/2014)... CMS recently has imposed a series ... inadequate access to prescription drugs. Agency audits are uncovering ... safety of beneficiaries in areas such as rejected pharmacy ... is taking quick and firm actions to halt them. ... “Avoiding Costly Part D Sanctions: Rx Access Strategies ...
(Date:7/25/2014)... 25, 2014 Yisrayl Hawkins, Pastor and Overseer ... on his blog explaining why so many prayers are going ... , In the article, Yisrayl gives many examples around ... the results. For example, in one case, in the small ... grounds to pray for rain; ironically, they received a massive ...
(Date:7/25/2014)... Yisrayl Hawkins, Pastor and Overseer of The House of Yahweh ... revealing to the whole world, including even the most devout ... in his new article. , Yisrayl says it all started ... by the Catholic Church. He says this plan included removing ... and replacing it with titles such as Lord and God. ...
(Date:7/25/2014)... According to the Hemorrhoid ... Vkool.com, this is a comprehensive guide that ... common types of hemorrhoids including:, ...     Young children with hemorrhoids , ...     Very large hemorrhoids and chronic hemorrhoids , ...
Breaking Medicine News(10 mins):Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 2Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 3Health News:Aug. 5 Webinar to Offer Strategies for Preventing Rx Access Issues and Avoiding Part D Sanctions 2Health News:Yisrayl Hawkins Says Prayers for Rain Result in Violent Hail Because Prayers Are Not Being Heard in New Post 2Health News:Yisrayl Hawkins Says Prayers for Rain Result in Violent Hail Because Prayers Are Not Being Heard in New Post 3Health News:Yisrayl Hawkins Says You Have Been Tricked Into Worshipping Satan in New Article 2Health News:Hemorrhoid No More Pdf Review Exposes Jessica Wright's Guide For Treating Hemorrhoids – Vkool.com 2Health News:Hemorrhoid No More Pdf Review Exposes Jessica Wright's Guide For Treating Hemorrhoids – Vkool.com 3
... SANTA MONICA, Calif., Oct. 8 Proposed,regulations that ... California stem cell research grants to for-profit organizations ... cures for California taxpayers,paying for the research, the ... "To ensure that the people who have ...
... Precise Surgical Laser Procedures, CAMBRIDGE, Mass., Oct. ... laser fibers for precision surgery, announced today,the launch ... procedures. The LightPath fiber features a fine ... safely conduct more precise procedures in Laryngology,Head & ...
... their own ... personal health info, PHILADELPHIA, Oct. ... largest organization of its,kind, will ask select groups of Americans to ... for,themselves, their children and ailing loved ones. At its 79th Annual,Convention ...
... like most, you eat worst at healthy restaurants., The ... treat themselves to higher-calorie side dishes, drinks or desserts ... no health claims, according to a series of new ... version of the Journal of Consumer Research , ...
... patients more likely to develop dementia, study finds ... people with Parkinson,s disease face up to a 73 ... new study that says genetics could be to blame. ... central nervous system, such as impaired motor skills and ...
... New research shows that selective serotonin reuptake inhibitors ... depression, may double the risk of gastrointestinal bleeding, according ... and colleagues. When the drugs are taken with aspirin ... than 600 percent higher. , Clinicians who prescribe these ...
Cached Medicine News:Health News:Revised California Stem Cell Research Rules Fail to Ensure Affordable Access to Cures, Consumers Warn 2Health News:OmniGuide Announces Launch of LightPath(TM) CO2 Laser Fiber 2Health News:AHIMA National Consumer Awareness Campaign Urges Patients to Assume Responsibility of Personal Health Records 2Health News:'Healthy' restaurants help make us fat, says a new Cornell study 2Health News:Parkinson's Linked to Risk of Alzheimer's 2Health News:Anti-depressant drugs can double risk of gastrointestinal bleeding 2Health News:Anti-depressant drugs can double risk of gastrointestinal bleeding 3
Silicone Foley Catheters 2-Way (Pediatric)...
Midstream Catch Kits...
Midstream Catch Kits...
... The Pediatric BladderScan® ... to Diagnostic Ultrasound's trusted ... By enabling healthcare providers ... bladder volume noninvasively, this ...
Medicine Products: